Temporal course of cognitive and behavioural changes in motor neuron diseases.
Temporal course of cognitive and behavioural changes in motor neuron diseases.
复制标题
运动神经元疾病认知和行为变化的时间过程。
DOI:
10.1136/jnnp-2023-331697
复制
发表时间:
2024
期刊:
影响因子:
--
通讯作者:
CReATeConsortium
中科院分区:
文献类型:
--
作者:
McHutchison,CarolineA;Wuu,Joanne;McMillan,CoreyT;Rademakers,Rosa;Statland,Jeffrey;Wu,Gang;Rampersaud,Evadnie;Myers,Jason;Hernandez,JessicaP;Abrahams,Sharon;Benatar,Michael;CReATeConsortium
BackgroundCognitive and behavioural dysfunction may occur in people with motor neuron disease (MND), with some studies suggesting an association with theC9ORF72repeat expansion. Their onset and progression, however, is poorly understood. We explored how cognition and behaviour change over time, and whether demographic, clinical and genetic factors impact these changes.MethodsParticipants with MND were recruited through the Phenotype-Genotype-Biomarker study. Every 3–6 months, the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was used to assess amyotrophic lateral sclerosis (ALS) specific (executive functioning, verbal fluency, language) and ALS non-specific (memory, visuospatial) functions. Informants reported on behaviour symptoms via semi-structured interview.ResultsParticipants with neuropsychological data at ≥3 visits were included (n=237, mean age=59, 60% male), of which 18 (8%) wereC9ORF72positive. Baseline cognitive impairment was apparent in 18 (8%), typically in ALS specific domains, and associated with lower education, but notC9ORF72status. Cognition, on average, remained stable over time, with two exceptions: (1)C9ORF72carriers declined in all ECAS domains, (2) 8%–9% of participants with baseline cognitive impairment further declined, primarily in the ALS non-specific domain, which was associated with less education. Behavioural symptoms were uncommon.ConclusionsIn this study, cognitive dysfunction was less common than previously reported and remained stable over time for most. However, cognition declines longitudinally in a small subset, which is not entirely related toC9ORF72status. Our findings raise questions about the timing of cognitive impairment in MND, and whether it arises during early clinically manifest disease or even prior to motor manifestations.